125 related articles for article (PubMed ID: 38282368)
1. Psychometric evaluation of the DePaul Symptom Questionnaire-Short Form (DSQ-SF) among adults with Long COVID, ME/CFS, and healthy controls: A machine learning approach.
McGarrigle WJ; Furst J; Jason LA
J Health Psychol; 2024 Jan; ():13591053231223882. PubMed ID: 38282368
[TBL] [Abstract][Full Text] [Related]
2. Improvement of Long COVID symptoms over one year.
Oliveira CR; Jason LA; Unutmaz D; Bateman L; Vernon SD
Front Med (Lausanne); 2022; 9():1065620. PubMed ID: 36698810
[TBL] [Abstract][Full Text] [Related]
3. The utility of patient-reported outcome measures among patients with myalgic encephalomyelitis/chronic fatigue syndrome.
Murdock KW; Wang XS; Shi Q; Cleeland CS; Fagundes CP; Vernon SD
Qual Life Res; 2017 Apr; 26(4):913-921. PubMed ID: 27600520
[TBL] [Abstract][Full Text] [Related]
4. Test-Retest Reliability of the DePaul Symptom Questionnaire.
Jason LA; So S; Brown AA; Sunnquist M; Evans M
Fatigue; 2015 Jan; 3(1):16-32. PubMed ID: 26973799
[TBL] [Abstract][Full Text] [Related]
5. The development of a short form of the DePaul Symptom Questionnaire.
Sunnquist M; Lazarus S; Jason LA
Rehabil Psychol; 2019 Nov; 64(4):453-462. PubMed ID: 31318234
[TBL] [Abstract][Full Text] [Related]
6. The DePaul Symptom Questionnaire-2: A Validation Study.
Bedree H; Sunnquist M; Jason LA
Fatigue; 2019; 7(3):166-179. PubMed ID: 32685281
[TBL] [Abstract][Full Text] [Related]
7. Medical Care Situation of People with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in Germany.
Froehlich L; Hattesohl DBR; Jason LA; Scheibenbogen C; Behrends U; Thoma M
Medicina (Kaunas); 2021 Jun; 57(7):. PubMed ID: 34201825
[No Abstract] [Full Text] [Related]
8. Differentiating Post-Polio Syndrome from Myalgic Encephalomyelitis and Chronic Fatigue Syndrome.
Klebek L; Sunnquist M; Jason LA
Fatigue; 2019; 7(4):196-206. PubMed ID: 33014628
[TBL] [Abstract][Full Text] [Related]
9. Fatigue and symptom-based clusters in post COVID-19 patients: a multicentre, prospective, observational cohort study.
Cornelissen MEB; Bloemsma LD; Vaes AW; Baalbaki N; Deng Q; Beijers RJHCG; Noij LCE; Houweling L; Bazdar S; Spruit MA; Maitland-van der Zee AH;
J Transl Med; 2024 Feb; 22(1):191. PubMed ID: 38383493
[TBL] [Abstract][Full Text] [Related]
10. A Brief Questionnaire to Assess Post-Exertional Malaise.
Cotler J; Holtzman C; Dudun C; Jason LA
Diagnostics (Basel); 2018 Sep; 8(3):. PubMed ID: 30208578
[TBL] [Abstract][Full Text] [Related]
11. Health outcomes of sensory hypersensitivities in myalgic encephalomyelitis/chronic fatigue syndrome and multiple sclerosis.
Maeda KI; Islam MF; Conroy KE; Jason L
Psychol Health Med; 2023 Dec; 28(10):3052-3063. PubMed ID: 36977713
[TBL] [Abstract][Full Text] [Related]
12. Identification of CD8 T-cell dysfunction associated with symptoms in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and Long COVID and treatment with a nebulized antioxidant/anti-pathogen agent in a retrospective case series.
Gil A; Hoag GE; Salerno JP; Hornig M; Klimas N; Selin LK
Brain Behav Immun Health; 2024 Mar; 36():100720. PubMed ID: 38327880
[TBL] [Abstract][Full Text] [Related]
13. The Development of the DePaul Symptom Questionnaire: Original, Expanded, Brief, and Pediatric Versions.
Jason LA; Sunnquist M
Front Pediatr; 2018; 6():330. PubMed ID: 30460215
[TBL] [Abstract][Full Text] [Related]
14. Orthostatic intolerance and neurocognitive impairment in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).
Gaglio CL; Islam MF; Cotler J; Jason LA
Epidemiol Methods; 2022 Jan; 11(1):20210033. PubMed ID: 36310761
[TBL] [Abstract][Full Text] [Related]
15. Activity monitoring and patient-reported outcome measures in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome patients.
Rekeland IG; Sørland K; Bruland O; Risa K; Alme K; Dahl O; Tronstad KJ; Mella O; Fluge Ø
PLoS One; 2022; 17(9):e0274472. PubMed ID: 36121803
[TBL] [Abstract][Full Text] [Related]
16. Validating a measure of myalgic encephalomyelitis/chronic fatigue syndrome symptomatology.
Brown AA; Jason LA
Fatigue; 2014; 2(3):132-152. PubMed ID: 27213118
[TBL] [Abstract][Full Text] [Related]
17. Proteomics and cytokine analyses distinguish myalgic encephalomyelitis/chronic fatigue syndrome cases from controls.
Giloteaux L; Li J; Hornig M; Lipkin WI; Ruppert D; Hanson MR
J Transl Med; 2023 May; 21(1):322. PubMed ID: 37179299
[TBL] [Abstract][Full Text] [Related]
18. A Cross-National Comparison of Myalgic Encephalomyelitis and Chronic Fatigue Syndrome at Tertiary Care Settings from the US and Spain.
Bhatia S; Olczyk N; Jason LA; Alegre J; Fuentes-Llanos J; Castro-Marrero J
Am J Soc Sci Humanit; 2020; 5(1):104-115. PubMed ID: 34109300
[TBL] [Abstract][Full Text] [Related]
19. Evidence for Peroxisomal Dysfunction and Dysregulation of the CDP-Choline Pathway in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
Che X; Brydges CR; Yu Y; Price A; Joshi S; Roy A; Lee B; Barupal DK; Cheng A; Palmer DM; Levine S; Peterson DL; Vernon SD; Bateman L; Hornig M; Montoya JG; Komaroff AL; Fiehn O; Lipkin WI
medRxiv; 2022 Jan; ():. PubMed ID: 35043127
[TBL] [Abstract][Full Text] [Related]
20. Psychometric properties of the PROMIS
Yang M; Keller S; Lin JS
Qual Life Res; 2019 Dec; 28(12):3375-3384. PubMed ID: 31506915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
